VRTX vs. SHEL

In the year-to-date period, VRTX achieves a 22.29% return, which is significantly higher than SHEL's 4.95% return. Over the past 10 years, VRTX has outperformed SHEL with an annualized return of 14.48%, while SHEL has yielded a comparatively lower 5.31% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and Shell plc (SHEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current VRTX Sharpe Ratio is 0.89, which is higher than the SHEL Sharpe Ratio of -0.28. The chart below compares the historical Sharpe Ratios of VRTX and SHEL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

VRTX has not paid dividends to shareholders, while SHEL's dividend yield for the trailing twelve months is around 4.27%.

The maximum VRTX drawdown since its inception was -91.77%, which is greater than SHEL's maximum drawdown of -67.46%. Use the drawdown chart below to compare losses from any high point for VRTX and SHEL. For additional features, visit the drawdowns tool.

The current volatility for Vertex Pharmaceuticals Incorporated (VRTX) is 7.37%, while Shell plc (SHEL) has a volatility of 15.40%. This indicates that VRTX experiences smaller price fluctuations and is considered to be less risky than SHEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Vertex Pharmaceuticals Incorporated and Shell plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.